Table 2 Antibiotic susceptibility pattern of K. pneumonia (n = 36)
Antibiotics | Class | Potency | Susceptible N (%) | Resistant N (%) |
|---|---|---|---|---|
Nitrofurantoin | Imidazolidinedione | 300 μg | 5(13.9) | 12(33.3) |
Ciprofloxacin | Fluoroquinolone | 5 μg | 3(8.3) | 33(91.7) |
Cotrimoxazole | Sulphonamide | 25 μg | 18 (50) | 18 (50) |
Amoxicillin/ Clavulanic Acid | β-lactam/ β-lactamase inhibitor combination | 20/10 μg | 11(30.6) | 25(69.4) |
Ampicillin/Sulbactum | β-lactam/ β-lactamase inhibitor combination | 10/10 μg | 11(30.6) | 25(69.4) |
Cefixime | Third generation Cephalosporin | 5 μg | 9(25) | 27(75) |
Ceftriaxone | Third generation Cephalosporin | 30 μg | 9(25) | 27(75) |
Ceftazidime | Third generation Cephalosporin | 30 μg | 9(25) | 27(75) |
Cefepime | Fourth generation Cephalosporin | 5 μg | 8(22.2) | 28(77.8) |
Cefotaxime | Third generation Cephalosporin | 30 μg | 7(19.4) | 29(80.6) |
Amikacin | Aminoglycoside | 30 μg | 15(41.7) | 21(58.3) |
Gentamicin | Aminoglycoside | 10 μg | 12(33.3) | 24 (66.7) |
Piperacillin/ Tazobactum | β-lactam/ β-lactamase inhibitor Combination | 100/10 μg | 12(33.3) | 24(66.7) |
Imipenem | Carbapenem | 10 μg | 11 (30.6) | 25(69.4) |
Meropenem | Carbapenem | 10 μg | 14(38.9) | 22(61.1) |